MarketInOut Stock Screener Log In | Sign Up

Evogene Ltd

TLV • Healthcare • Biotechnology • Quote as of 10/30/2026
Evogene Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTLV
Market Capitalization15.83 mln
Float9.96 mln
Earnings Date11/20/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-3.72
Highly reliable

Relative Strength

40 / 100
Slightly lagging

Debt / Equity

0.36
Low leverage

Pre-Tax Margin

-1,199%
Severely loss-making

ROE

-183
Deeply negative

Business Description

Evogene is an Israeli biotechnology company that uses advanced computational tools to drive innovation across agriculture, medicine, and industrial applications. Its work spans developing better crop traits, discovering new drug candidates through AI-powered molecule design, and producing castor bean seeds for industrial use. The company also works on medical cannabis and is partnering with a leading German university hospital to explore treatments for serious inflammatory conditions. Founded in 1999 and based in Rehovot, Israel, Evogene operates across markets in the United States, Europe, and Africa.

Key Fundamentals

EPS-4.94
ROE-183
RPS0.32
ROIC-125
ROA-38.41
Interest Cover-2.73
EBITDA, mln-31.47
EV / EBITDA-0.68
EV / EBIT-0.63
Revenue, mln4.14
EV / Revenue5.20

Quote Details

Last 116.20
Change 1.7 (1.48%)
Open 113.00
Volume 37,830
Turnover 4,395,846
Average Volume 90,930

Financial Ratios

Pre-Tax Profit Margin-1,199
Current Ratio3.57
Price / Book1.01
Price / Tangible Book1.01
Debt / Equity0.36
Price / Sales3.00

Financial Strength

Altman Z-Score-31.79
Piotroski F-Score 2 / 9
Beneish M-Score-3.72

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.26% 67 / 100   
1 Month 2.56% 80 / 100   
2 Months -32.64% 4 / 100   
6 Months -52.53% 4 / 100   
1 Year -72.09% 2 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog